{"id":49591,"date":"2022-10-13T15:01:45","date_gmt":"2022-10-13T13:01:45","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/"},"modified":"2022-10-13T15:01:45","modified_gmt":"2022-10-13T13:01:45","slug":"iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/","title":{"rendered":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence"},"content":{"rendered":"
\n

\nPartnership brings Iterative Scopes\u2019 AI Recruitment technology to <\/i>One GI<\/i>\u00ae<\/i>\n<\/p>\n

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes<\/a>, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI<\/a>\u00ae, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI\u2019s clinical research. Initially, One GI\u00ae will use AIR at Gastro One, one of One GI\u2019s clinical research sites in Memphis, Tennessee, with plans to expand to additional research sites within the One GI\u00ae network. The implementation of AIR will aid in the recruitment of patients for clinical trials focused on inflammatory bowel disease (IBD).\n<\/p>\n

<\/a><\/p>\n

\nBoth One GI\u00ae and Iterative Scopes are fast-growing innovators in the gastroenterology space. One GI\u00ae is a unique, rapidly expanding MSO that brings together community-based practices, including Gastro One, a network of six practices across Tennessee. The MSO currently has 40 sites within its network across Tennessee, Mississippi, Kentucky, Ohio, and Indiana. Iterative Scopes is a pioneer in the application of powerful, proprietary artificial intelligence tools to the practice of gastroenterology and drug development.\n<\/p>\n

\nThe partnership between the two organizations will allow One GI\u00ae physicians to leverage the AI-based technology from Iterative Scopes to standardize the endoscopic scoring process for patients and identify likely eligible patients to enroll in IBD clinical trials. By initiating the collaboration at Gastro One, the organizations are taking initial steps to develop a hub and spoke recruitment model for One GI\u00ae, which will democratize access to the novel IBD therapeutics for all patients, regardless of where they receive care.\n<\/p>\n

\n\u201cOur partnership with Iterative Scopes enables the delivery of innovative technology to community-based gastroenterology practices, demonstrating One GI\u2019s commitment to physician-centered, patient-focused healthcare,\u201d said Robbie Allen, CEO of One GI\u00ae. \u201cOur ultimate mission is to power practices \u2013 regardless of their location \u2013 to deliver world class GI care, and implementing AIR will allow a broader array of patients to access potentially life-changing clinical trials.\u201d\n<\/p>\n

\n\u201cIn addition to helping us offer the most advanced patient care, this partnership fuels the continuous growth of our research department so that we remain at the forefront of GI care, improving outcomes and patients\u2019 lives,\u201d said Richard Aycock, MD, Gastro One senior physician. \u201cDr. Ziad Younes, a global leader in gastroenterology, is pioneering the program within our practices, and we\u2019re enthusiastic about the potential to help advance the GI field even further.\u201d\n<\/p>\n

\nAIR works to simplify the process of matching patients to clinical trials by helping gastroenterologists better understand disease severity more quickly and consistently. The technology uses computational algorithms integrated with existing colonoscopy imagery and videos to determine clinical trial eligibility, speeding up the clinical trial timelines and allowing more patients to access potentially life-changing treatments. The company\u2019s technology automates scoring of a patient\u2019s minimum threshold score of disease severity, as measured by the Mayo Endoscopic Score (MES), as an aid in determining their qualification for pre-screening for IBD clinical trials. Iterative Scopes has already partnered with multiple clinical research sites for IBD and is continuing to expand its reach with notable partners like One GI\u00ae.\n<\/p>\n

\n\u201cIterative Scopes\u2019 mission is to democratize access to high quality care for patients struggling with IBD and other GI conditions, ultimately reducing healthcare disparities in clinical practice,\u201d said Sahir Raoof, VP of Business Development at Iterative Scopes. \u201cWe are thrilled to be partnering with Dr. Younes and One GI\u00ae to drive clinical adoption of artificial intelligence to help us advance clinical trial recruitment in an effort to help bring novel therapeutics to IBD patients faster.\u201d\n<\/p>\n

\nTo learn more about Iterative Scopes and AI-Recruitment, visit the company\u2019s website: https:\/\/www.iterativescopes.com\/<\/a>\n<\/p>\n

\nAbout Iterative Scopes
\n
<\/b>Iterative Scopes is a pioneer in the application of artificial intelligence-based precision medicine for gastroenterology with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). The technology is also designed to potentially enhance colorectal cancer screenings. Its powerful, proprietary artificial intelligence and computer vision technologies have the potential to improve the accuracy and consistency of endoscopy readings. Iterative Scopes is initially applying these advances to impact polyp detection for colorectal cancer screenings and working to standardize disease severity characterization for inflammatory bowel disease. Longer term, the company plans to establish more meaningful endpoints for GI diseases, which may be better predictors of therapeutic response and disease outcomes. The company is based in Cambridge, Massachusetts.\n<\/p>\n

\nAbout One GI
\n
<\/b>One GI\u00ae, the Home for Independent Gastroenterology, is a gastroenterology management services organization that partners with GI physicians empowering them to manage, optimize, and grow their practices. One GI provides state of the art resources to physicians so they can focus on what they do best: providing excellent care to patients. For additional information on One GI, please visit www.onegi.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nHannah Fier
\n
Matter Health for Iterative Scopes
\n
iterativescopes@matternow.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Partnership brings Iterative Scopes\u2019 AI Recruitment technology to One GI\u00ae CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI\u00ae, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI\u2019s clinical research. Initially, One GI\u00ae will use AIR at … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49591","6":"format-standard","7":"category-industry"},"yoast_head":"\nIterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Partnership brings Iterative Scopes\u2019 AI Recruitment technology to One GI\u00ae CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI\u00ae, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI\u2019s clinical research. Initially, One GI\u00ae will use AIR at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-13T13:01:45+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence\",\"datePublished\":\"2022-10-13T13:01:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/\"},\"wordCount\":817,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005177\\\/en\\\/1600467\\\/21\\\/Iterative_Scopes_Logo_with_Text_%282%29.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/\",\"name\":\"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005177\\\/en\\\/1600467\\\/21\\\/Iterative_Scopes_Logo_with_Text_%282%29.jpg\",\"datePublished\":\"2022-10-13T13:01:45+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005177\\\/en\\\/1600467\\\/21\\\/Iterative_Scopes_Logo_with_Text_%282%29.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221013005177\\\/en\\\/1600467\\\/21\\\/Iterative_Scopes_Logo_with_Text_%282%29.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/","og_locale":"en_US","og_type":"article","og_title":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend","og_description":"Partnership brings Iterative Scopes\u2019 AI Recruitment technology to One GI\u00ae CAMBRIDGE, Mass.–(BUSINESS WIRE)–Iterative Scopes, a pioneer in precision-medicine technologies for gastroenterology, announced today that it has partnered with One GI\u00ae, a gastroenterology management services organization (MSO), to bring its AI Recruitment (AIR) technology to One GI\u2019s clinical research. Initially, One GI\u00ae will use AIR at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-13T13:01:45+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence","datePublished":"2022-10-13T13:01:45+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/"},"wordCount":817,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/","url":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/","name":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg","datePublished":"2022-10-13T13:01:45+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221013005177\/en\/1600467\/21\/Iterative_Scopes_Logo_with_Text_%282%29.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/iterative-scopes-partners-with-one-gi-to-advance-gastrointestinal-care-through-artificial-intelligence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Iterative Scopes Partners with One GI\u00ae to Advance Gastrointestinal Care Through Artificial Intelligence"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49591","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49591"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49591\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49591"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49591"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49591"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}